Literature DB >> 25065535

A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.

C Barrowclough1, M Marshall1, L Gregg1, M Fitzsimmons2, B Tomenson3, J Warburton2, F Lobban4.   

Abstract

BACKGROUND: Cannabis use is high amongst young people who have recently had their first episode of psychosis, and is associated with worse outcomes. To date, interventions to reduce cannabis consumption have been largely ineffective, and it has been suggested that longer treatment periods are required.
METHOD: In a pragmatic single-blind randomized controlled trial 110 participants were randomly allocated to one of three conditions: a brief motivational interviewing and cognitive behavioural therapy (MI-CBT) intervention (up to 12 sessions over 4.5 months) with standard care from an early intervention service; a long MI-CBT intervention (up to 24 sessions over 9 months) with standard care; or standard care alone. The primary outcome was change in cannabis use as measured by Timeline Followback.
RESULTS: Neither the extended nor the brief interventions conferred benefit over standard care in terms of reductions in frequency or amount of cannabis use. Also the interventions did not result in improvements in the assessed clinical outcomes, including symptoms, functioning, hospital admissions or relapse.
CONCLUSIONS: Integrated MI and CBT for people with cannabis use and recent-onset psychosis does not reduce cannabis use or improve clinical outcomes. These findings are consistent with those in the published literature, and additionally demonstrate that offering a more extended intervention does not confer any advantage. Many participants were not at an action stage for change and for those not ready to reduce or quit cannabis, targeting associated problems rather than the cannabis use per se may be the best current strategy for mental health services to adopt.

Entities:  

Mesh:

Year:  2014        PMID: 25065535     DOI: 10.1017/S0033291714000208

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  12 in total

1.  Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.

Authors:  Dustin C Lee; Nicolas J Schlienz; Erica N Peters; Robert H Dworkin; Dennis C Turk; Eric C Strain; Ryan Vandrey
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

Review 2.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

Review 3.  [Motivational interviewing : A possibility for doctor-patient communication in schizophrenia?]

Authors:  Jens Reimer; Jens Kuhn; Rita Wietfeld; Wolfgang Janetzky; Karolina Leopold
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

4.  Behavioral Interventions for Individuals Dually-Diagnosed with a Severe Mental Illness and a Substance Use Disorder.

Authors:  Clara M Bradizza; Paul R Stasiewicz; Kurt H Dermen
Journal:  Curr Addict Rep       Date:  2014-12-01

5.  Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis.

Authors:  Abigail C Wright; Julia Browne; Corinne Cather; Piper Meyer-Kalos; Kim T Mueser
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-28       Impact factor: 5.760

6.  Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial.

Authors:  Itxaso González-Ortega; Enrique Echeburúa; Susana Alberich; Miguel Bernardo; Eduard Vieta; Gonzalo Salazar de Pablo; Ana González-Pinto
Journal:  Int J Environ Res Public Health       Date:  2022-06-15       Impact factor: 4.614

7.  The impact of cannabis use on clinical outcomes in recent onset psychosis.

Authors:  Christine Barrowclough; Lynsey Gregg; Fiona Lobban; Sandra Bucci; Richard Emsley
Journal:  Schizophr Bull       Date:  2014-07-09       Impact factor: 9.306

8.  Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.

Authors:  Christopher Jones; David Hacker; Jun Xia; Alan Meaden; Claire B Irving; Sai Zhao; Jue Chen; Chunhu Shi
Journal:  Cochrane Database Syst Rev       Date:  2018-12-20

9.  Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.

Authors:  Itxaso González-Ortega; Enrique Echeburúa; Adriana García-Alocén; Patricia Vega; Ana González-Pinto
Journal:  Trials       Date:  2016-07-29       Impact factor: 2.279

10.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.